跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOXORUBICIN-EBEWE INJ 50MG/25ML (VIAL) - PPB Drug Approval Details
Approvals
/
PPB
/
DOXORUBICIN-EBEWE INJ 50MG/25ML (VIAL)
Approved
STANDARD
DOXORUBICIN-EBEWE INJ 50MG/25ML (VIAL)
SANDOZ HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
e749a6673ed0f84d
Company
SANDOZ HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
e749a6673ed0f84d
Product Name
DOXORUBICIN-EBEWE INJ 50MG/25ML (VIAL)
Drug Hk Name
DOXORUBICIN-EBEWE INJ 50MG/25ML (VIAL)
Registration Code
HK-37493
Company Name
SANDOZ HONG KONG LIMITED
Company Detail Path
/organization/sandoz-hong-kong-limited
Registration Category
Antibiotic
Sale Requirement
Prescription only Medicines
Registration Date
1994-04-06
Company Address
UNIT 2901, NO. 28 STANLEY STREET, CENTRAL, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
e749a6673ed0f84d
Type
Standard
Back to PPB Approvals